2 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 2 |
Follow Shi Yanxia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer Olanzapine Tablets, Placebo - Olanzapine, CINV | Phase 3 | Unknown | Shi Yanxia | 75 | 2022-01-18 | 2023-02-06 |
| PERS Genetic Model Assistant Decision-making System of Neoadjuvant Chemotherapy for Breast Cancer NVB, EPI, DDP - Breast Cancer Model, Effects of Chemotherapy | Phase 3 | Unknown | Shi Yanxia | 320 | 2016-04-01 | 2017-01-16 |
Breast Neoplasms (1) · Nausea (1) · Testicular Neoplasms (1) · Vomiting (1)
Capecitabine (1) · Cisplatin (1) · Docetaxel (1) · Epirubicin (1) · Gemcitabine (1) · Olanzapine (1) · Protons (1) · Trastuzumab (1) · Vinorelbine (1)
China (2)
YanXia Shi, doctor (1) · Yanxia Shi, PHD (1)